K. Madsen

Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer

M. Karsdal, C. Hansen, J. Johansen, 2022, International journal of cancer.

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).

M. Donia, I. Svane, E. Høgdall, 2022, European journal of cancer.

Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy

C. Johansen, H. Schmidt, I. Svane, 2023, Acta oncologica.

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma

T. Hansen, L. Jensen, C. Hansen, 2023, Cancers.

Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

S. Brunak, I. Svane, B. Jensen, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

M. Donia, I. Svane, S. Hadrup, 2023, Frontiers in Immunology.

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer

L. Jensen, C. Hansen, J. Johansen, 2023, Cancers.

Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay

J. Johansen, E. Maag, D. Nielsen, 2022, Clinical Proteomics.

Satisfaction with and perceived benefits of needs-assessment related to rehabilitation after chemotherapy among patients with breast cancer.

M. Mikkelsen, D. Nielsen, K. Madsen, 2023, Disability and rehabilitation.